Willem J. Klokman

Late cardiotoxicity after treatment for Hodgkin lymphoma

Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Marie L. De Bruin et al. · Blood · 2006 · 766 citations · Full text

Medicine, Hematology, Oncology +12

Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Willem J. Klokman et al. · Journal of Clinical Oncology · 2003 · 717 citations

Medicine, Geriatric Medicine, Cancer Epidemiology +16

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

Flora E. van Leeuwen, Willem J. Klokman, Anton Hagenbeek et al. · Journal of Clinical Oncology · 1994 · 449 citations

Medicine, Oncology, Pathology +14

Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood

Flora E. van Leeuwen, Willem J. Klokman, Mars B. vanʼt Veer et al. · Journal of Clinical Oncology · 2000 · 438 citations

Medicine, Oncology, Cancer Epidemiology +16

Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease

Flora E. van Leeuwen, Willem J. Klokman, Marilyn Stovall et al. · JNCI Journal of the National Cancer Institute · 2003 · 395 citations

Medicine, Oncology, Radiation Oncology +16